Strepsils Dry Cough

Quick links

Choose a section

Quick links to important sections

Advertisements

Strepsils Dry Cough

Advertisements
Advertisements

Treatment option: Cough

Advertisements

Overview of Strepsils Dry Cough

Property Description
Active ingredient Dextromethorphan Hydrobromide
Form Oral Solution (Syrup)
Pharmacological class Antitussive Agent (Cough Suppressant)
Common use Symptomatic relief of dry, non-productive cough
Origin Synthetic

Defining the Preparation: Antitussive Agent Classification

Strepsils Dry Cough is classified as a single-ingredient medicine belonging to the antitussive agent class, specifically designed to suppress the cough reflex to provide symptomatic relief. This product is an Oral Solution, often presented as a syrup, and is categorized as an Over-The-Counter (OTC) medicine. The classification as a non-opioid, centrally acting antitussive is clinically recognized. The medicine’s primary function is to help reduce the frequency and intensity of persistent, dry coughing.

Core Composition and Nature: Dextromethorphan Hydrobromide

The sole active ingredient of this preparation is Dextromethorphan Hydrobromide (INN). The compound is synthetic and functions as a focused antitussive, being widely researched for its low potential for dependency compared to certain older antitussive compounds.

The product's liquid dosage form and aqueous solution base ensure effective systemic absorption of the Dextromethorphan Hydrobromide. This formulation is distinct because it is not combined with expectorants or decongestants, emphasizing a targeted monotherapy approach specifically for the central suppression of cough irritation.

General Purpose: Relief for Non-Productive Cough

The general purpose of using this preparation is to diminish the severity and occurrence of a dry cough or persistent non-productive cough. The therapeutic focus is on easing patient discomfort when the cough serves no physiological function for clearing the airways. The medication achieves this by modulating the medullary cough center, effectively reducing the responsiveness of the involuntary cough reflex. This pharmacological mechanism confirms its utility in dampening the irritating urge to cough.

Regulatory References

  1. Dextromethorphan: MedlinePlus Drug Information
Advertisements

What side effects are possible with Strepsils Dry Cough?

Possible Side Effects and Safety Information

The safety profile of Strepsils Dry Cough, which contains Dextromethorphan Hydrobromide, is defined by officially documented adverse reactions classified by frequency and the body system affected. All safety information is based on authoritative government regulatory documents.


Adverse Reaction Classifications

Side effects are typically categorized by the frequency observed in clinical use and are grouped by the affected System-Organ Class (SOC) as defined in regulatory labeling.

Common Adverse Reactions (may affect up to 1 in 10 people) generally involve the Nervous System and Gastrointestinal System.

System-Organ Class Common Adverse Reactions
Nervous System Disorders Dizziness, Somnolence (drowsiness)
Gastrointestinal Disorders Nausea, Vomiting, Gastrointestinal disturbances

Uncommon and Rare adverse reactions include certain Skin and Subcutaneous Tissue Disorders (such as rash or pruritus) and Immune System Disorders (hypersensitivity reactions).


Serious Safety Considerations and Constraints

The product labeling documents the potential for Serotonin Syndrome, a serious adverse reaction, particularly when Dextromethorphan is used concurrently with specific medications, such as Monoamine Oxidase Inhibitors (MAOIs). This interaction is a formal Contraindication in official regulatory documents, meaning the medicine must not be used in individuals taking an MAOI or within 14 days of stopping one.

Population-specific safety notes are included for certain patient groups. Caution is formally advised for Older Adults, who may show increased sensitivity to the central nervous system effects. Similarly, safety notes apply to patients with existing Hepatic Impairment due to the drug’s metabolism. The product is not intended for use with a chronic cough, such as that associated with conditions like asthma.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information

Overdose of Strepsils Dry Cough (Dextromethorphan Hydrobromide) requires immediate medical attention and is defined by regulatory authorities based on specific symptom clusters and the need for urgent management.

Documented Overdose Presentations

System Manifestations Described in Official Labeling
CNS Drowsiness, confusion, agitation, ataxia (unsteadiness), nystagmus (involuntary eye movements), and hallucinations.
Cardiopulmonary Fast heartbeat (tachycardia) and high blood pressure, with a critical risk of respiratory depression (slowed or shallow breathing).
Gastrointestinal Nausea and vomiting are documented signs.

Severe Outcomes and Management

Severe outcomes noted in regulatory documents include seizures, coma, and Serotonin Syndrome risk (especially if taken with MAOIs or SSRIs). Breathing problems, including apnea, are specifically highlighted as a risk for young children.

Immediate Medical Action is Mandated:

  • Seek immediate medical attention or Get medical help right away if overdose is suspected.
  • Call emergency services (e.g., 911) if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.
  • Contact the Poison Control Helpline immediately for guidance.

Management procedures described in official information involve symptomatic and supportive treatment, including the use of activated charcoal and continuous monitoring of vital signs and ECG. Naloxone is cited in regulatory contexts as an antagonist successfully used in managing Dextromethorphan toxicity.

Advertisements

Therapeutic Uses of Strepsils Dry Cough

What Strepsils Dry Cough Treats: Main Uses and Benefits

Strepsils Dry Cough (Dextromethorphan Hydrobromide) is commonly used to provide supportive therapeutic relief from acute, non-productive coughing associated with minor airway irritations. The active ingredient, Dextromethorphan, is commonly used to temporarily ease cough associated with the common cold, the flu, or other conditions.


Relief for Dry, Irritative Symptoms

This preparation is commonly used for managing the dry, hacking cough or non-productive cough pattern that may occur during the acute phase of an illness. It is relevant for easing the frequent, persistent tickling sensation in the throat, a symptom related to heightened physiological activity that may interfere with daily functioning. This medication is applied across domains where additional symptomatic support is needed, focusing on symptomatic relief in conditions characterized by episodic or fluctuating cough patterns, including coughs linked to the common cold and certain seasonal allergic reactions.

Support for Improved Comfort and Rest

Short-term symptomatic support may assist with maintaining functional stability during difficult episodes and contributes to improved comfort during periods of heightened symptoms. The medication is applied in clinical settings marked by heightened patient distress, particularly when persistent coughing leads to sleep disruption or fatigue. It contributes to easing the overall symptom load when coughing episodes become noticeable or disruptive. This medication is relevant for easing symptoms experienced by adults and older pediatric groups.


Quick Fact: Symptomatic Relief Focus

Strepsils Dry Cough is used in situations involving certain distressing symptoms and applied across domains where short-term symptom management is appropriate, supporting the patient during episodes of heightened discomfort.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Strepsils Dry Cough?

This section defines the official eligibility for Strepsils Dry Cough lozenges, which typically contain the antiseptics 2,4-Dichlorobenzyl alcohol and Amylmetacresol, and sometimes the cough suppressant Dextromethorphan depending on the specific product formulation (check the label).

Who Must Not Use This Medicine (Contraindicated):

  • Patients with a known hypersensitivity or allergy to any of the product's ingredients.
  • Individuals with rare hereditary sugar intolerance problems (e.g., fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency) due to excipient content.
  • If the formulation contains Dextromethorphan, it is strictly contraindicated with Monoamine Oxidase Inhibitors (MAOIs), or within two weeks of stopping MAOI therapy, due to the risk of a severe drug interaction called serotonin syndrome.

Age Restrictions and Special Considerations:

  • Children: Use is not suitable for children under 6 years of age due to the choking hazard presented by lozenges. Consult product packaging for age rules specific to Dextromethorphan-containing versions, which may have higher age limits.
  • Pregnancy and Lactation: Use during pregnancy or breastfeeding is restricted and requires a doctor's or pharmacist's consultation before use, as the product's safety in these states has not been fully established.
  • Chronic Conditions: Individuals with a persistent or chronic cough (such as that caused by smoking, asthma, or emphysema) or a cough accompanied by excessive phlegm should consult a doctor before use.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Strepsils Dry Cough, which contains Dextromethorphan Hydrobromide, is defined by regulatory-mandated restrictions primarily concerning its metabolism and pharmacologic activity.

Contraindicated and High-Risk Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated. This includes MAOIs such as Isocarboxazid, Phenelzine, and Selegiline. Due to the severe risk of Serotonin Syndrome, a mandatory 14-day washout period is required after the last dose of any MAOI before Dextromethorphan can be taken.

Interaction Type Interacting Substances Official Regulatory Outcome
Pharmacokinetic Strong CYP2D6 Inhibitors (e.g., Fluoxetine, Quinidine) Increased plasma concentration (exposure) of Dextromethorphan
Pharmacodynamic Serotonergic Agents (e.g., SSRIs, SNRIs) Documented risk of Serotonin Syndrome due to additive effects
Substance Alcohol (Ethanol) Additive Central Nervous System (CNS) depressant effects

Co-administration with strong CYP2D6 inhibitors may significantly reduce the clearance of Dextromethorphan. Furthermore, use with other serotonergic agents, including certain antidepressants, carries a documented risk for Serotonin Syndrome due to cumulative effects. The use of alcohol is documented to increase CNS depressant effects. Individuals identified as CYP2D6 Poor Metabolizers are noted in official labeling to be at higher risk for exaggerated effects from these interactions.

Advertisements

Mechanism of Action

Strepsils Dry Cough contains dextromethorphan (DMP), a compound that functions mechanistically by binding to sigma-1 (sigma1) receptors. The primary site of action is within the central nervous system, specifically the medulla oblongata, a brainstem region critical for regulating the cough reflex.

The binding of DMP to the sigma1 receptor modulates the afferent neural signaling originating from the respiratory tract. This molecular interaction interrupts the neuronal feedback loop in the central cough network, thereby diminishing the excitability required to initiate the cough response.

As a result of this central pathway inhibition, the generation of coughs is suppressed. This neurophysiological modulation represents the mechanism by which the compound influences the respiratory system, maintaining its effect purely within the domain of pharmacological dynamics.

Advertisements

Dosage and Administration Information

How to Use Strepsils Dry Cough

Strepsils Dry Cough, containing Dextromethorphan Hydrobromide, is administered via the oral route as a liquid solution or syrup. The usage protocol is defined by specific, time-bound instructions and strict dose ceilings outlined in official documentation to ensure controlled, short-term use.


Official Dosing and Frequency Guidelines

Administration is an as-needed process, limited by a mandated time interval between doses and a maximum daily total.

Age Group Standard Single Dose Range Minimum Dosing Interval Maximum Daily Dose (24 hours)
Adults & Adolescents (12+ years) 10 mg to 20 mg 4 to 6 hours 80 mg
Children (6 to 12 years) 5 mg to 10 mg 4 to 6 hours 40 mg

Administration Requirements

The correct usage of the oral solution requires careful adherence to the following procedural conditions:

  • Accurate Measurement: Doses must be measured using the dosing cup or device supplied with the product to ensure the accurate delivery of the labeled dose.
  • Preparation: The solution is designed for direct oral intake and requires no further dilution or reconstitution prior to administration.
  • Concurrent Use Constraint: Official instructions stipulate that the product must not be used simultaneously with other cough and cold remedies that contain Dextromethorphan or similar antitussive agents, reinforcing the 24-hour dose maximum.
  • Duration: The medicine is intended for short-term symptomatic treatment only. For patients with hepatic impairment, caution should be exercised.
Advertisements

Recent Clinical Evidence

Recent Clinical Evidence: Dextromethorphan

The active compound in Strepsils Dry Cough is Dextromethorphan (DXM), an antitussive agent approved for use as a cough suppressant. Research concerning DXM lozenges typically focuses on their role in managing non-productive (dry) cough associated with conditions like the common cold or upper respiratory tract infections.

Clinical Trial Overview

Studies evaluating the antitussive effect of DXM for acute cough have often compared it against a placebo or an active comparator. The primary challenge in assessing cough medicines lies in the symptom's natural variability and the substantial placebo effect observed in trials for acute respiratory illnesses. Research findings regarding the clinically significant efficacy of DXM in treating cough associated with upper respiratory tract infections remain mixed.

Study Focus Population Key Finding Type
Antitussive Effect (Single Dose) Adults with acute cough from URTIs Statistically significant difference observed in one objective measure (cough sound pressure level) at one time point (90 mins) versus placebo.
Post-Intubation Cough Smokers undergoing general anesthesia Use of lozenges containing the active ingredients prior to surgery was associated with a decrease in reported cough and sore throat post-extubation.

Safety and Tolerability

Clinical data indicates that at the doses found in over-the-counter products, the compound is generally associated with a favorable safety profile. The most commonly reported adverse events in the studied populations include mild gastrointestinal discomfort (e.g., nausea) and some central nervous system effects such as dizziness or mild drowsiness. These events are typically transient.

Research has not definitively established the compound's use in specific, complex populations, such as individuals with pre-existing liver conditions. Use in combination with certain medications, particularly those affecting serotonin levels (like some antidepressants), may warrant professional oversight due to the potential for interaction.

Key Studies & References

  1. Dextromethorphan - StatPearls (Source for mechanism, safety, and regulatory approval/indication)
  2. Dextromethorphan: MedlinePlus Drug Information (Source for common side effects and use)
  3. Dextromethorphan Pediatric Acute Cough Study (CHPA DXM) - ClinicalTrials.gov (Study on methodology and objective cough measurement)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Strepsils Dry Cough (FAQ)

Q: Can Strepsils Dry Cough be used for a cough that is worse at night?

A: According to official product information, Dextromethorphan is approved to temporarily relieve cough caused by common conditions. The official guidelines do not specify use only for daytime or nighttime coughs. The medicine is intended to be used by following a specified time interval between doses for when the next dose may be taken as needed for symptoms.

Q: Will Strepsils Dry Cough help with a cough caused by allergies or post-nasal drip?

A: The product is approved for the symptomatic relief of a dry cough associated with conditions like the common cold or upper respiratory tract infections. Regulatory documents do not specifically list coughs caused by allergies or post-nasal drip as approved uses for this single-ingredient medicine.

Q: Can Strepsils Dry Cough cause a dry mouth or throat irritation?

A: Official adverse event summaries for single-ingredient Dextromethorphan do not commonly list dry mouth or throat irritation. The most frequently reported side effects relate to the central nervous system, such as dizziness and drowsiness, and the gastrointestinal system, like nausea and vomiting.

Q: Are there any foods or drinks that should be avoided while using Strepsils Dry Cough?

A: Regulatory warnings indicate that the use of alcohol (ethanol) concurrently is cautioned against due to the potential for increased Central Nervous System (CNS) depressant effects, such as drowsiness. Some official materials also indicate that the concurrent consumption of grapefruit or grapefruit juice may potentially increase the concentration of the medicine in the blood.

Q: Can Strepsils Dry Cough be used if a person is taking common medication for high blood pressure?

A: Unlike certain decongestants, single-ingredient Dextromethorphan is not generally known to raise blood pressure. Official labeling advises that individuals with pre-existing medical conditions, including high blood pressure (hypertension), consult a healthcare professional before use to ensure suitability with existing treatments.

Q: What information is available about the effects of taking too many Strepsils Dry Cough lozenges?

A: Exceeding the recommended dosage can lead to effects described in official safety documents. These effects may include blurred vision, drowsiness, confusion, hallucinations, nausea, vomiting, or a rapid heartbeat. The potential for more severe effects may be increased if the medicine is used in conjunction with certain interacting medications.

Q: What are the general guidelines if a person accidentally misses a dose of Strepsils Dry Cough?

A: Since this medicine is typically used 'as needed' for symptoms, general guidelines describe a strategy where if a dose is missed, it may be taken when remembered, unless it is near the time for the next scheduled dose. Skipping the missed dose in that scenario is described as a way to avoid exceeding the recommended daily maximum.

Q: Is the taste of Strepsils Dry Cough linked to its active ingredient?

A: Scientific studies show that Dextromethorphan, the active ingredient, may activate certain bitter taste receptors in the mouth. This information is often a consideration during product formulation, which uses excipients (flavors) to improve its taste and palatability.

Q: Is it true that Strepsils Dry Cough can cause confusion if misused?

A: Confusion is listed as an uncommon adverse effect associated with Dextromethorphan hydrobromide. Regulatory warnings and reports state that in cases of misuse or abuse at very high doses, the drug can cause mental confusion and altered states of consciousness.

Q: What should a patient generally expect if Strepsils Dry Cough does not relieve the cough symptoms?

A: Official product information advises that if the cough symptoms persist for more than seven days, return after going away, or are accompanied by a fever, rash, or persistent headache, these issues indicate that the medicine should be stopped. Official guidance is that if these issues occur, discontinuation of use and consultation with a healthcare professional are advised.

Q: How long does the cough suppression effect of one lozenge of Strepsils Dry Cough last?

A: While the exact pharmacological duration of the effect is not definitively stated in all official documents, the maximum time interval between doses acts as a general guide. Official dosing instructions for Dextromethorphan-containing products stipulate a minimum time interval of four to six hours between doses.

Q: Is Strepsils Dry Cough considered an antihistamine or a decongestant?

A: According to official regulatory classifications, Dextromethorphan, the active ingredient, is in a class of medications called antitussives, which are cough suppressants. It is a centrally-acting compound and is not classified as an antihistamine or a decongestant.

Q: What is the difference between Strepsils Dry Cough and the regular Strepsils Sore Throat lozenges?

A: Strepsils Dry Cough (Oral Solution) contains Dextromethorphan Hydrobromide, which is a centrally-acting cough suppressant designed to treat a dry cough. Regular Strepsils Sore Throat lozenges typically contain different ingredients, such as antiseptics, which are intended specifically to relieve sore throat pain.

Q: Does Strepsils Dry Cough contain codeine or similar narcotic ingredients?

A: Dextromethorphan is officially classified as a non-opioid cough suppressant. It is chemically related to older antitussive compounds like codeine but does not possess the same analgesic (pain-relieving) or addictive properties as those narcotic substances.

Q: What is the recommended maximum duration for continuously using Strepsils Dry Cough?

A: The medicine is intended only for short-term symptomatic treatment of a dry cough. Official product information advises that if the cough symptoms persist for more than seven days, use should be stopped, and consultation with a healthcare professional is advised.

Q: Does Strepsils Dry Cough affect the ability to drive or operate machinery?

A: Official documents state that this medicine can impair cognitive function due to its action on the central nervous system. Because side effects like dizziness and drowsiness are common, the patient’s ability to drive safely or operate machinery may be affected.

Q: Are there warnings about using Strepsils Dry Cough for people with kidney or liver issues?

A: Regulatory documents formally advise that caution should be exercised for patients with existing hepatic impairment (liver problems) due to how the drug is metabolized in the body. Warnings regarding use in patients with kidney (renal) impairment are not consistently noted in the official product information for this single-ingredient formulation.

Q: Can individuals with diabetes use Strepsils Dry Cough lozenges?

A: The oral solution formulation may contain simple sugars (e.g., liquid glucose) as excipients. Official labeling for such products often advises that the sugar content must be taken into account by patients with diabetes mellitus. Reviewing the full excipient list on the package leaflet is a common practice for individuals with diabetes.

Q: Does Strepsils Dry Cough contain sugar substitutes that I should be aware of?

A: While the specific excipient list is not provided, many liquid cough medicines may contain a combination of simple sugars and sugar substitutes (such as acesulfame K or sodium cyclamate). Patients with specific dietary needs or conditions commonly check the full list of ingredients on the product’s package leaflet.

Q: What are the common signs of an allergic reaction to Strepsils Dry Cough?

A: Hypersensitivity reactions are listed in regulatory documents as rare adverse effects. Signs of a severe allergic reaction may include rash, hives, swelling (especially of the face or throat), and difficulty breathing. Official guidance emphasizes that if these signs occur, immediate medical assistance should be considered.

Q: Why is there a age restriction for Strepsils Dry Cough?

A: The oral solution formulation is approved for use in children aged 6 years and older, with specific dosing provided for the 6–12 age group. For the lozenge form, the restriction for children under 6 years is specifically noted in official documents due to the risk of choking.

Q: Can I use Strepsils Dry Cough if I also have a mild sore throat?

A: The active ingredient in this product, Dextromethorphan, is solely a cough suppressant and is not indicated for treating pain symptoms like a sore throat. However, Dextromethorphan is sometimes formulated in multi-ingredient products that may include other agents approved for pain or sore throat relief.

Advertisements

How should Strepsils Dry Cough be stored and disposed of?

How to Store and Dispose of Strepsils Dry Cough

Storage of Strepsils Dry Cough (Dextromethorphan Hydrobromide) must follow official regulatory requirements to ensure product stability.


Storage Requirements

Condition Requirement
Temperature Must be stored at room temperature, generally not above 25°C (77°F), and should not be refrigerated or allowed to freeze.
Protection Keep out of the reach and sight of children. Store in the original container and outer carton, protected from light.
Stability The oral solution must be used within a specific period after first opening the bottle, as stated on the product label.

Disposal Instructions

Expired or unused Strepsils Dry Cough must not be disposed of via household waste or wastewater. Follow instructions to return the product to a pharmacy or local collection service designated for medicinal waste to ensure proper handling and environmental protection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Strepsils Dry Cough found in:

A-Z Index: